Adding GM-CSF to Ipilimumab Extends Survival in Metastatic Melanoma

Adding GM-CSF to ipilimumab extends survival in metastatic melanoma

Filed under: willard drug treatment center

"We are waiting for the data to mature in ongoing studies examining the relative efficacy of 3 mg/kg and 10 mg/kg dosing," said Dr. Hodi, director of the melanoma center at Dana-Farber Cancer Institute in Boston. … "We have been using GM-CSF in …
Read more on The Oncology Report

Lenore A4412544 – A4412544 Lenore is a dynamic two year old tricolor female American Staffordshire Bull Terrier mix who was discarded at the Downey Animal Care Center on April…